Impact of 2018 ESC/ESH and 2017 ACC/AHA Hypertension Guidelines: Difference in Prevalence of White-Coat and Masked Hypertension
Our study evaluated whether there were differences in the prevalence of white-coat hypertension (WH) and masked hypertension (MH) based on the 2018 ESC/ESH and 2017 ACC/AHA hypertension guidelines in Korea. The motivation was the lowering of the diagnostic threshold for hypertension in the 2017 ACC/...
Main Authors: | Byong-Kyu Kim, Moo-Yong Rhee |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-05-01
|
Series: | Healthcare |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9032/8/2/122 |
Similar Items
-
Initial combination treatment in the 2018 ESC/ESH hypertension guidelines
by: Giuseppe Mancia
Published: (2019-08-01) -
White-coat hypertension and masked hypertension: an update
by: Nathan Artom, et al.
Published: (2015-10-01) -
CONTEMPORARY PROBLEMS OF EVALUATION OF HYPERTENSION TREATMENT EFFICACY: MASKED HYPERTENSION AND WHITE COAT HYPERTENSION
by: V. M. Gorbunov, et al.
Published: (2016-01-01) -
The role of beta-blockers in the treatment of hypertension in 2018 ESC/ESH guidelines
by: A. O. Konradi, et al.
Published: (2018-12-01) -
White Coat Hypertension and Masked Hypertension Among Omani Patients Attending a Tertiary Hospital for Ambulatory Blood Pressure Monitoring
by: Khamis Al-Hashmi, et al.
Published: (2015-03-01)